Top Markets
Coin of the day
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVB
Pozycja w akcjach #99999
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the... Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
Cena akcji
$0.09933121
Kapitalizacja rynkowa
$29.15K
Zmiana (1 dzień)
0.57%
Zmiana (1 rok)
449.49%
Kraj
IE
Handel Ovoca Bio plc (OVB)

Kategoria

Zyski dla Ovoca Bio plc (OVB)
Zyski w Jun 2024 TTM: $-5.54M
Według najnowszych raportów finansowych Ovoca Bio plc, obecny zysk firmy wynosi $-5.54M. W roku 2023 firma osiągnęła zysk w wysokości $-5.64M, wzrost w porównaniu do zysku z roku 2022, który wynosił $-6.02M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Ovoca Bio plc od 2001 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $-5.54M 177,402.36%
2024 $-3.12K -99.94%
2023 $-5.64M -6.27%
2022 $-6.02M 0.89%
2021 $-5.97M 111.35%
2020 $-2.82M 32.29%
2019 $-2.13M -6.96%
2018 $-2.29M 401.73%
2017 $-457.16K -54.69%
2016 $-1.01M -58.18%
2015 $-2.41M -69.99%
2014 $-8.04M -60.54%
2013 $-20.37M 592.33%
2012 $-2.94M -153.33%
2011 $5.52M 340.98%
2010 $1.25M -87.44%
2009 $9.96M -683.08%
2008 $-1.71M 36.71%
2007 $-1.25M -81.83%
2006 $-6.88M 549.04%
2005 $-1.06M 285.00%
2004 $-275.29K 10.93%
2003 $-248.17K 96.02%
2002 $-126.60K -32.76%
2001 $-188.29K 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$20.46B -369,289.88%
DK
$4.64B -83,895.77%
US
$5.23B -94,498.38%
US
$2.14B -38,678.95%
BE
$1.45B -26,287.63%
NL